W6 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

what does CCNA stand for?

A

Canadian Consortium on Neurodegeneration in Aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the aim of the CCNA?

A

national initiative aimed at tackling the growing onset of dementia and related illnesses and improving the lives of Canadians with illnesses and families and caregivers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

who was the Minister of Health that launched the CCNA?

A

Rona Ambrose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the 3 themes for research?

A
  • delaying onset
  • prevention
  • improve QOL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what was the general aim of CCNA?

A

combine expertise from across Canada and multiple disciplines
- broaden understanding of how NDD develop and the impact
- determine how to prevent, delay, modify progression and cope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the 4 objectives of CCNA?

A
  • strengthen and synergize research
  • become Canadian hub for leading and participating in international research
  • reinforce international positioning, competitiveness and impact of Canadian research at global level
  • improve QOL and quality of services
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the 4 categories that are integrated?

A
  • research
  • synergy
  • talent
  • inclusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the orientation to prevention?

A

primary
secondary
tertiary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is primary prevention?

A

protect healthy individuals from developing NDD
- risk assessment
- education about PFs
- risk reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is secondary prevention?

A

stop or delay the progress of NDD after risk classification or early diagnosis
- risk control and management
- monitor disease progress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is tertiary prevention?

A

manage disease progress -> co-morbidities that may exacerbate rate of disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what was phase1 of CCNA?

A

funding from multiple sources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what was participant flow in COMPASS-ND?

A
  • recruitment into CCNA
  • informed consent signed
  • history, physical, cognitive eval
  • questionnaires
  • psychometric testing
  • biosamples - blood, saliva, CSF
  • sample processing
  • sample shipping to biobank
  • mri imaging acquistion
  • mri it and databasing
  • brain donation program and follow-up in clinic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the 6 goals of CCNA phase 2?

A
  • understanding subgroups
  • develop or test new treatment molecules
  • develop prevention strategies
  • allow earlier diagnosis
  • innovate life improvements
  • optimize health care delivery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the platforms associated with CCNA?

A

neuroimaging
can-thumbs up
Loris
COMPASS-ND

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how many teams are there for CCNA?

A

19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the cross-cutting programs?

A
  • knowledge translation and exchange
  • training and capacity building
  • women, sex, gender, dementia
  • ethical, legal and social implications
  • engagement of people with lived experience
  • indigenous cog health
  • social inclusion and stigma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the NDD diagnoses approach 1?

A

focus on “pure” cases of each (strict inclusion and exclusion criteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the narrow focus on approach 1?

A

craft diagnostic criteria to produce homogenous groups that represent a fraction of dementia population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the purity involved with approach 1?

A

exclude co-morbidities and mixed dementias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what was NDD diagnosis approach 2?

A

broader choice of inclusion and exclusion criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the inclusivity of approach 2?

A

broadly inclusive will produce heterogenous groups that will cover entire dementia population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is the ecological representation of approach 2?

A

includes almost all co-morbidities and mixed

24
Q

what is the rationale behind approach 2?

A

difficult to specify criteria and detect pure disease cases

25
Q

what is the limitation to approach 2?

A

heterogeneity within diagnostic groups

26
Q

what is NDD diagnosis approach 3?

A

moderate application of inclusion and exclusion criteria

27
Q

what is the compromise with approach 3?

A

“rather broad” criteria: produce less homogenous groups that represent most of dementia pop

28
Q

who is represented in approach 3?

A

co-morbidities and mixed dementias

29
Q

are all mixed diseases included in approach 3?

A

no only most

30
Q

who will be excluded from approach 3?

A

brain disease
major psychiatric disturbance
drug addiction

31
Q

what model did Kaarin Ansety create?

A

CHELM

32
Q

what does CHELM stand for?

A

cognitive health environment lifecourse model

33
Q

what approach is close to CHELM?

A

CLASS

34
Q

why is the CHELM approach similar to CLASS?

A
  • core ideas in brain/cog aging and dementia
  • importance of longitudinal approaches
  • adding multi-modal RF to DPM
35
Q

what is the overlap and relatedness between CHELM and CLASS?

A

differential changes, intra-individual, mechanisms, plasticity
cascades of risk (broader focus)

36
Q

what are the 2 types of reserve capacity?

A

brain: passive, cognition affected after accumulation of pathology
cognitive: active, cognition continues despite brain pathology

37
Q

what is the chain for the CHELM model?

A

biomarkers to RF -> controllable RF -> modifiable RF -> bio-clinical outcomes -> prism of neurocognitive resources -> cognitive or clinical outcomes

38
Q

what is the Lancet Commission?

A

comprehensive review
- life course projection

39
Q

how many modifiable RFs are there?

A

12
- education
- hearing loss
- hypertension
- obesity
- alcohol/tbi
- smoking
- depression
- physical inactivity
- social isolation
- diabetes
- air pollution

40
Q

what are the 3 identified mechanisms of ND risk?

A
  • reduction in brain/cognitive reserve/resilience
  • increasing brain damage as a fxn of disease and insult
  • spreading brain inflammation
41
Q

what is the goal of the Lancet?

A

aim for reducing specific RF in order to modify risk mechanisms

42
Q

what is Anstey’s “umbrella review”?

A

systematic review of world-wide evidence on RFs of dementia

43
Q

what are the 3 conclusions from Anstey’s review?

A
  • evidence base varies by NDD
  • lack of “early” effect evidence
  • much variability in geographical representation of evidence
44
Q

what is the IRNDP?

A

international research network on dementia prevention
- how systematic and diverse studies of RA can contribute to understanding differential pathways toward or away from ADRD

45
Q

who founded IRNDP?

A

Anstey

46
Q

what is the purpose of the risk assessment?

A

allows for early detection of risk and for application to RCTs and RR protocol

47
Q

what are the 6 health factors contributing to vascular risk for unhealthy brain aging and dementia?

A

stroke
obesity
smoking
high cholesterol
hypertension
diabetes

48
Q

what are the 4 points from CULTURAL?

A
  • need for cross-national and cultural investigations
  • need for linking RFs with associated mechanisms
  • need for harmonization
  • exploring new research targetsw
49
Q

what is the summary of CULTURAL?

A

scientific, ethical, and practical imperative to expand dementia risk and prevention research across nations, cultures, regions and under-represented populations

50
Q

what are the 4 directions for the IRNDP research?

A
  • expand diversity research
  • expand attention to life course exposure variations
  • expand evidence base
  • expand long-term follow-up research
51
Q

what are some social determinants of health affecting degree of or access to potential RF change?

A
  • income and social status
  • education and literacy
  • employment and working conditions
  • early childhood development
  • physical environment and housing
  • social supports
  • access to health services
  • biology and genetics
  • gender
  • culture
  • race
  • disability and ableism
52
Q

what is the principle of SSDH?

A

person’s social and structural “context” affects RF, RR, possibilities for modifying risk or protection

53
Q

what are SSDH?

A

non-medical, social, and economic factors that occur within everyday and working conditions of people and substantially influence the extent and direction of dementia risk

54
Q

what are the challenges of SSDH?

A

modifiable RF and PF do not operate uniformly or universally, but only within the SSDH context of individuals

55
Q

what is the implication of SSDH?

A

effectiveness of interventions to modify RFs and PFs depend on SSDH context

56
Q

what are the communities of dementia and dementia risk?

A
  • indigenous - growing # of older Ind and impacts of social determinants of health
  • racialized - ethnic profile of older people is growing
  • sex and gender
  • chronological age - early onset poses a challenge
57
Q

what is the Tom Kitwood quote?

A

when you’ve met one person with dementia, you’ve met one person with dementia